Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Special Report
Aust Covid Vaccine Tracker

Posted 22 December 2020

Overseas regulators have recently opened the gates to two mRNA Covid vaccines with Pfizer's candidate developed in partnership with BioNTech now approved in the US and Europe.

European Union countries including Germany, France, Austria and Italy have said they plan to start vaccinations from December 27 after the European Commission conditionally approved the vaccine, while the first shots have already been administered in the US under an emergency use authorisation.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
PBAC March agenda
Every major and minor sub sorted by indication
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas
Special Report
November 2020 PBAC outcomes
Just over half of submissions recommended